Open access · CC-BY
via OpenAlex
One-carbon metabolism: An aging-cancer crossroad for the gerosuppressant metformin
Javier Abel Menéndez, Jorge Joven
Aging · 2013 · ▲ 21 citations
Abstract
The gerosuppressant metformin operates as an efficient inhibitor of the mTOR(definition)/S6K1 gerogenic pathway due to its ability to ultimately activate the energy-sensor AMPK. If an aging-related decline in the AMPK sensitivity to cellular stress is a crucial event for mTOR-driven aging and aging-related diseases, including cancer, unraveling new proximal causes through which AMPK activation endows its gerosuppressive effects may offer not only a better understanding of metformin function but also the likely possibility of repositioning our existing gerosuppressant drugs. Here we provide our perspective on recent findings suggesting that de novo biosynthesis of purine nucleotides, which is based on the metabolism of one-carbon compounds, is a new target for metformin's actions at the crossroads of aging and cancer.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.18632/aging.100523
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Menéndez, J.A., & Joven, J. (2013). One-carbon metabolism: An aging-cancer crossroad for the gerosuppressant metformin. <em>Aging</em>. https://doi.org/10.18632/aging.100523
Vancouver
Menéndez JA, Joven J. One-carbon metabolism: An aging-cancer crossroad for the gerosuppressant metformin. Aging. 2013. doi:10.18632/aging.100523.
BibTeX
@article{javier2013Onecar,
title = {One-carbon metabolism: An aging-cancer crossroad for the gerosuppressant metformin},
author = {Javier Abel Menéndez and Jorge Joven},
journal = {Aging},
year = {2013},
doi = {10.18632/aging.100523},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Education Health and Sport 2025
Open access · CC-BY
Metformin - An Antidiabetic Drug With Anti-aging, Cardioprotective And Potential Anti-cancer Properties
Diabetes Obesity and Metabolism 2026
Open access · OA
Amino acid metabolism modulates chronic kidney disease progression by mediating the aging process: Mechanistic insights and therapeutic interventions
Annals of the New York Academy of Sciences 2016
Open access · OA
Reverse geroscience: how does exposure to early diseases accelerate the age‐related decline in health?
Cell Metabolism 2013
Open access · OA
Metformin, Microbes, and Aging
Jurnal Kedokteran dan Kesehatan Publikasi Ilmiah Fakultas Kedokteran Universitas Sriwijaya 2025
Open access · CC-BY
ADVANTAGES AND DISADVANTAGES OF USING METFORMIN IN AGING RELATED DISEASES
International Journal of Research in Pharmacology & Pharmacotherapeutics 2025
Open access · OA